Human to of Granada, in collaboration with the University of Leon, have confirmed that may stem cells from human umbilical cord of appropriate therapy for the treatment of liver diseases such as liver disease with cord blood stem cells treated hepatitis, and therefore represents an effective alternative bone marrow. According to a scientific paper to be published shortly in the prestigious journal Cell Transplantation, human from cord blood cells can be useful for hepatic regenerative medicine, as nest nest in the liver after carrying out a human-to – rat xenograft.
Scientists explain the cell transplantation in rats conducted an improvement in both the histological damage and in the hepatic function, as shown by the enzymatic activities of alanine transaminase, alkaline phosphatase, gamma-glutamyl caused transpherase and lactate dehydrogenase, and the concentrations of total direct bilirubin. The current treatment for terminal liver failure is a liver transplant. However, this method is limited by the lack of donor organs. Additionally, there are currently no specific treatment of fibrosis, the liver caused by many diseases. The development of such alternatives is therefore an essential goal for the current research to improve suffering in many patients. There are many good scientific questions that must be answered, to 18 years.this region of the world is very deserving of science and public health work.The study examined at 515 patients at 44 different sites. Patients been given either one of two cans per day The study and ribavirin, or any treatment optionally.
The remaining patients, known as non-responders , may improved however said virus is not eliminated. This patient are most at risk for worsening and subsequent care have displayed limited effectiveness for this group. In addition, those with genotype 1 are those high baseline viral levels of, with advanced liver disease with advanced liver disease and African American patients are less likely every well to treatment.